Laboratory-Based Markers as Predictors of Brain Infarction During Carotid Stenting: a Prospective Study

. 2016 Jul 01 ; 23 (7) : 839-47. [epub] 20160119

Jazyk angličtina Země Japonsko Médium print-electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid26783048

AIM: New ischemic lesions in the brain can be detected in approximately 50% of patients undergoing carotid artery stenting (CAS). We wished to discover the laboratory-based predictors of new infarctions in the brain after CAS. METHODS: All consecutive patients with internal carotid artery stenosis of ≥70% with indication for CAS were enrolled in a prospective study for 16 months. All patients used dual antiplatelet therapy for ≥7 days before CAS. Neurologic examination and magnetic resonance imaging (MRI) of the brain were undertaken before and at 24 h after CAS. Samples of venous blood were collected at <24 h before CAS for the evaluation of hematology, reticulocytes, coagulation markers (PT, APTT, Fbg, Clauss), vWF antigen, PAI-1 activity, PAI-1 polymorphism 4G/5G, and the multiplate (aspirin and clopidogrel) resistance test. Blood samples for the assessment of anti-Xa activity were collected during CAS. Differences in the values of laboratory markers between patients with and without new ischemic lesions of the brain on control MRI were evaluated. RESULTS: The cohort comprised 81 patients (53 males; mean age, 67.3±7.2 years). New ischemic infarctions in the brain on control MRI were found in 46 (56.8%) patients. Three of seven patients with resistance to aspirin or clopidogrel had a new ischemic infarction in the brain. No significant differences for particular markers were found between patients with and without an ischemic lesion in the brain. CONCLUSION: A high risk of a new ischemic infarction in the brain was detected in patients undergoing CAS, but a laboratory-based predictor of such an infarction could not be identified.

Zobrazit více v PubMed

Tegos TJ, Kalodiki E, Daskalopoulou SS, Nicolaides AN: Stroke: epidemiology, clinical picture, and risk factors-Part I of III. Angiology, 2000; 51: 793-808 PubMed

Mohr JP, Choi DW, Grotta JC, Weir B, Wolf PA: Stroke: Pathophysiology, Diagnosis, and Management. Philadelphia: Elsevier Inc, 4th Edition, 2004

Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, Rankin RN, Clagett GP, Hachinski VC, Sackett DL, Thorpe KE, Meldrum HE, Spence JD: Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med, 1998; 339: 1415-1425 PubMed

Rothwell PM, Gutnikov SA, Warlow CP: European Carotid Surgery Trialist's Collaboration. Reanalysis of the final results of the European Carotid Surgery Trial. Stroke, 2003; 34: 514-523 PubMed

Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA, 1995; 273: 1421-1428 PubMed

Skoloudik D: Neurosonologie, Grada, Praha, Czech Republic, 2003

Yavin D, Roberts DJ, Tso M, Sutherland GR, Eliasziw M, Wong JH: Carotid endarterectomy versus stenting: a meta-analysis of randomized trials. Can J Neurol Sci, 2011; 38: 230-235 PubMed

Economopoulos KP, Sergentanis TN, Tsivgoulis G, Mariolis AD, Stefanadis C: Carotid artery stenting versus carotid endarterectomy: a comprehensive meta-analysis of short-term and long-term outcomes. Stroke, 2011; 42: 687-692 PubMed

Bonati LH, Jongen LM, Haller S, Flach HZ, Dobson J, Nederkoorn PJ, Macdonald S, Gaines PA, Waaijer A, Stierli P, Jäger HR, Lyrer PA, Kappelle LJ, Wetzel SG, van der Lugt A, Mali WP, Brown MM, van der Worp HB, Engelter ST, ICSS-MRI study group : New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS). Lancet Neurol, 2010; 9: 353-362 PubMed

Schnaudigel S, Gröschel K, Pilgram SM, Kastrup A: New brain lesions after carotid stenting versus carotid endarterectomy: a systematic review of the literature. Stroke, 2008; 39: 1911-1919 PubMed

Kuliha M, Roubec M, Procházka V, Jonszta T, Hrbáč T, Havelka J, Goldírová A, Langová K, Herzig R, Školoudík D: Randomized clinical trial comparing neurological outcomes after carotid endarterectomy or stenting. Br J Surg, 2015; 102: 194-201 PubMed

Pasternak RC, Baughman KL, Fallon JT, Block PC: Scanning electron microscopy after coronary transluminal angioplasty of normal canine coronary arteries. Am J Cardiol, 1980; 45: 591-598 PubMed

Grunwald IQ, Reith W, Kühn AL, Balami JS, Karp K, Fassbender K, Walter S, Papanagiotou P, Krick C: Proximal protection with the Gore PAES can reduce DWI lesion size in high-grade stenosis during carotid stenting. EuroIntervention, 2014; 10: 271-276 PubMed

Vucković BA, Djerić MJ, Ilić TA, Canak VB, Kojić-Damjanov SLj, Zarkov MG, Cabarkapa VS: Fibrinolytic parameters, lipid status and lipoprotein(a) in ischemic stroke patients. Srp Arh Celok Lek, 2010; 138 (Suppl 1: 12-17 PubMed

Enomoto Y, Yoshimura S: Antiplatelet therapy for carotid artery stenting. Interv Neurol, 2013; 1: 151-163 PubMed PMC

Ryu DS, Hong CK, Sim YS, Kim CH, Jung JY, Joo JY: Anti-platelet drug resistance in the prediction of thromboembolic complications after neurointervention. J Korean Neurosurg Soc, 2010; 48: 319-324 PubMed PMC

Hovens MM, Snoep JD, Eikenboom JC, van der Bom JG, Mertens BJ, Huisman MV: Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review. Am Heart J, 2007; 153: 175-181 PubMed

Mansour K, Taher AT, Musallam KM, Alam S: Aspirin resistance. Adv Hematol, 2009; 2009: 937352. PubMed PMC

Feher G, Feher A, Pusch G, Koltai K, Tibold A, Gasztonyi B, Papp E, Szapary L, Kesmarky G, Toth K: Clinical importance of aspirin and clopidogrel resistance. World J Cardiol, 2010; 2: 171-186 PubMed PMC

Heyer EJ, Sharma R, Rampersad A, Winfree CJ, Mack WJ, Solomon RA, Todd GJ, McCormick PC, McMurtry JG, Quest DO, Stern Y, Lazar RM, Connolly ES: A controlled prospective study of neuropsychological dysfunction following carotid endarterectomy. Arch Neurol, 2002; 59: 217-222 PubMed PMC

Gurbel PA, Antonino MJ, Tantry US: Recent developments in clopidogrel pharmacology and their relation to clinical outcomes. Expert Opin Drug Metab Toxicol, 2009; 5: 989-1004 PubMed

Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines; American Stroke Association; American Association of Neuroscience Nurses; American Association of Neurological Surgeons; American College of Radiology; American Society of Neuroradiology; Congress of Neurological Surgeons; Society of Atherosclerosis Imaging and Prevention; Society for Cardiovascular Angiography and Interventions; Society of Interventional Radiology; Society of NeuroInterventional Surgery; Society for Vascular Medicine; Society for Vascular Surgery; American Academy of Neurology and Society of Cardiovascular Computed Tomography 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/ SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary. Stroke, 2011; 42: 420-463 PubMed

Al-Azzam SI, Alzoubi KH, Khabour O, Alowidi A, Tawalbeh D. The prevalence and factors associated with aspirin resistance in patients premedicated with aspirin. Acta Cardiol, 2012; 67: 445-448 PubMed

von Pape KW, Dzijan-Horn M, Bohner J, Spannagl M, Weisser H, Calatzis A. Control of aspirin effect in chronic cardiovascular patients using two whole blood platelet function assay: PFA-100 and Multiplate. Hamostaseologie, 2007; 27: 155-160 PubMed

Ranucci M, Baryshnikova E, Soro G, Ballotta A, De Benedetti D, Conti D, Surgical and Clinical Outcome Research (SCORE) Group Multiple electrode whole-blood aggregometry and bleeding in cardiac surgery patients receiving thienopyridines. Ann Thorac Surg, 2011; 91: 123-129 PubMed

Sibbing D, Braun S, Morath T, Mehilli J, Vogt W, Schömig A, Kastrati A, von Beckerath N. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. J Am Coll Cardiol, 2009; 53: 849-856 PubMed

von Reutern GM, Goertler MW, Bornstein NM, Del Sette M, Evans DH, Hetzel A, Kaps M, Perren F, Razumovky A, von Reutern M, Shiogai T, Titianova E, Traubner P, Venketasubramanian N, Wong LK, Yasaka M, Neurosonology Research Group of the World Federation of Neurology : Grading carotid stenosis using ultrasonic methods. Stroke, 2012; 43: 916-921 PubMed

Ferguson GG, Eliasziw M, Barr HW, Clagett GP, Barnes RW, Wallace MC, Taylor DW, Haynes RB, Finan JW, Hachinski VC, Barnett H: The North American Symptomatic Carotid Endarterectomy Trial: surgical results in 1415 patients. Stroke, 1999; 30: 1751-1758 PubMed

Tedesco MM, Coogan SM, Dalman RL, Haukoos JS, Lane B, Loh C, Penkar TS, Lee JT. Risk factors for developing postprocedural microemboli following carotid interventions. J Endovasc Ther, 2007; 14: 561-567 PubMed

Hammer FD, Lacroix V, Duprez T, Grandin C, Verhelst R, Peeters A, Cosnard G. Cerebral microembolization after protected carotid artery stenting in surgical high-risk patients: results of a 2-year prospective study. J Vasc Surg, 2005; 42: 847-853 PubMed

du Mesnil de Rochemont R, Schneider S, Yan B, Lehr A, Sitzer M, Berkefeld J: Diffusion-weighted MR imaging lesions after filter-protected stenting of high-grade symptomatic carotid artery stenoses. AJNR Am J Neuroradiol, 2006; 27: 1321-1325 PubMed PMC

Tedesco MM, Lee JT, Dalman RL, Lane B, Loh C, Haukoos JS, Rapp JH, Coogan SM: Postprocedural microembolic events following carotid surgery and carotid angioplasty and stenting. J Vasc Surg, 2007; 46: 244-250 PubMed

Paraskevas KI, Lazaridis C, Andrews CM, Veith FJ, Giannoukas AD: Comparison of cognitive function after carotid artery stenting versus carotid endarterectomy. Eur J Vasc Endovasc Surg, 2014; 47: 221-231 PubMed

Sandercock PA, Counsell C, Gubitz GJ, Tseng MC: Antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev, 2008; 3: CD000029 PubMed

Aikawa H, Kodama T, Nii K, Tsutsumi M, Onizuka M, Iko M, Matsubara S, Etou H, Sakamoto K, Kazekawa K: Intraprocedural plaque protrusion resulting in cerebral embolism during carotid angioplasty with stenting. Radiat Med, 2008; 26: 318-323 PubMed

Rosenkranz M, Wittkugel O, Waiblinger C, Thomalla G, Krutzelmann A, Havemeister S, Zeumer H, Gerloff C, Fiehler J: Cerebral embolism during carotid artery stenting: role of carotid plaque echolucency. Cerebrovasc Dis, 2009; 27: 443-449 PubMed

Faggioli G, Ferri M, Rapezzi C, Tonon C, Manzoli L, Stella A: Atherosclerotic aortic lesions increase the risk of cerebral embolism during carotid stenting in patients with complex aortic arch anatomy. J Vasc Surg, 2009; 49: 80-85 PubMed

Jiang L, Ling F, Wang B, Miao Z: Insight into the periprocedural embolic events of internal carotid artery angioplasty. A report of four cases and literature review. Interv Neuroradiol, 2011; 17: 452-458 PubMed PMC

Censori B, Camerlingo M, Casto L, Partziguian T, Caverni L, Bonaldi G, Mamoli A: Carotid stents are not a source of microemboli late after deployment. Acta Neurol Scand, 2000; 102: 27-30 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...